Pacific Biosciences of California Inc. News
PacBio (Still) Lags on This Crucial Metric
The genomics company PacBio isn't making much progress in the most important source of revenue.
Invitae Goes Full Meme Stock. What's Next?
Shares of the genetic testing company have more than doubled in less than a week. It likely isn't durable.
Illumina and the Quest for the (Holy?) Grail
DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.
10x Genomics Stock Rebound Depends on Growth
The formerly high-flying growth stock is stalling against macroeconomic headwinds. How quickly can the business get back on track?
A Beaten-Down Biotech Stock That's Finally Attractive
This lab-hardware business is growing, cashed up, and close to profitability.
Cathie Wood's Ark Continues Tech-Stock Buying Spree
On Wednesday, Ark snapped up shares of Twilio, Roblox, Coinbase and JD.com. It sold Twitter and Palantir Technologies.
Invitae Surges as SoftBank Leads $1.15 Billion Investment
Invitae says a $1.15 billion investment from a Softbank-led group will support the medical-genetics company's growth opportunities.
Pacific Biosciences Rises as SoftBank Invests $900 Million
Pacific Biosciences says Softbank's $900 million investment 'validates our leadership position in the long-read DNA sequencing market.'
Young Investors Playlist: Cramer's 'Mad Money' Recap (Tuesday 12/8/20)
Jim Cramer says young investors may have unorthodox investing ideas, but their strategies are working. Here's what they're buying.
U.S. Kills Iranian General, Oil Prices Surge, FOMC to Release Minutes - 5 Things You Must Know Friday
U.S. stock futures sink and oil prices surge after a U.S. military strike kills Gen. Qassem Soleimani, a top Iranian general; the U.S. economic calendar includes the ISM Manufacturing Index for December and minutes from the Federal Reserve’s Dec. 10-11 meeting; Illumina abandons $1.2 billion acquisition of Pacific Biosciences.
Breaking News
Target Stock Slides As Discounts Clip Margins, Sharply Trim Q2 Earnings
"While these inventory actions put significant pressure on our near-term profitability, we're confident this was the right long-term decision," said CEO Brian Cornell.
Taking Social Security? Retirees May Get a Big COLA Bump Up in 2023.
U.S. retirees may get a big benefit with the next Social Security cost-of-living adjustment for 2023.
Retail Sales Stall In July, But Core Spending Gains As Gas Prices Tumble
Core retail sales improved firmly in July, but the headline figure was essentially unchanged as gas prices tumbled from their June record highs.
Amazon Makes Serious Accusations Against a Powerful Regulator
E-commerce giant Amazon is the subject of a major investigation linked to its Prime service. It's not sitting idly by.